Company news
Treace Medical Concepts, Inc. news in 2024
Treace Medical Concepts, Inc.'s news releases, calls and decks from 2024, newest first.
Treace Expands Reach into High-Volume Osteotomy Market with Second MIS Osteotomy Platform, Percuplasty™ Percutaneous 3D Bunion Correction® Procedure
December 29, 2024
Treace Announces First Surgical Cases Utilizing the SpeedPlate™ MicroQuad™ Implant
December 15, 2024
Treace Announces First Cases Utilizing RedPoint™ Intelliguide™ Patient Specific Instrumentation with the Adductoplasty® System for Correction of Midfoot Deformities
December 3, 2024
Treace Appoints Guy Guglielmino as Chief Commercial Officer
December 1, 2024
Treace Medical Concepts Reports Third Quarter 2024 Financial Results
November 4, 2024
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
November 3, 2024
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
October 21, 2024
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
October 13, 2024
Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024
September 10, 2024
Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 21, 2024
Treace Medical Concepts Reports Second Quarter 2024 Financial Results
August 5, 2024
Treace Medical Concepts Reports First Quarter 2024 Financial Results
May 6, 2024
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
April 23, 2024
Treace Announces First Annual National Bunion Day
April 15, 2024
Treace to Report First Quarter 2024 Financial Results
April 8, 2024
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
March 24, 2024
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
February 26, 2024
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
February 6, 2024
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
February 1, 2024
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
January 7, 2024
Calls in 2024
Decks in 2024
- Q1 2024 Earnings Presentation
Earnings · 14 slides · May 7, 2024
- Q4 2023 Earnings Presentation
Earnings · 19 slides · Feb 27, 2024
- 42nd Annual J.P. Morgan Healthcare Conference (January 2024)
Conference · 29 slides · Jan 10, 2024